Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Liver Int. 2018 Dec 28;39(5):826–834. doi: 10.1111/liv.14014

Figure 1.

Figure 1.

Percentage of patients who achieved target not detected (TND, solid line), and predicted to reach cure at specific time points during treatment based on extracellular body fluid (CL-EF, dashed line) and time to HCV-infected hepatocytes clearance (CL-C, dotted line) cure boundaries.